Publications

Yeast fungaemia among injection drug users in France (2012–2022): a cross-sectional observational study

Publié en janvier 2025 Lancet Regional Health Europe
janvier 2025

Is there still a place for serum galactomannan in the diagnosis of invasive aspergillosis in children at high risk and under antifungal prophylaxis?

Lancet Regional Health Europe
Publication précédente
janvier 2025

Autochthonous Trichophyton rubrum terbinafine resistance in France: assessment of antifungal susceptibility tests

Lancet Regional Health Europe
Publication suivante

Auteurs

  • Paccoud
    O.
    Lortholary
    O.
    Imbert
    S.
    Letscher-Bru
    V.
    Boukris-Sitbon
    K.
    Obadia
    T.
    Dalle
    F.
    Hasseine
    L.
    Morio
    F.
    Huguenin
    A.
    Poirier
    P.
    Favennec
    L.
    Bonhomme
    J.
    Alanio
    A.
    Lanternier
    F.
    Desnos-Ollivier
    M.